HUTCHMED (China) HMDCF
NASDAQ HMDCF
$2.16 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

HUTCHMED (China) (HMDCF) Operating Income (2018 - 2021)

HUTCHMED (China)'s (HMDCF) quarterly Operating Income came in at $227.3 million in Q1 2021, up 60.7% year-over-year from $141.5 million in Q1 2020, and up 319.28% quarter-over-quarter from $54.2 million in Q2 2020.

Analysis

HUTCHMED (China) (HMDCF) Operating Income (2018 - 2021) Analysis & Trends

HUTCHMED (China) (HMDCF) has reported Operating Income for 4 consecutive years, with $227.3 million the latest figure, recorded in Q1 2021.

  • On a quarterly basis, Operating Income rose 60.7% year-over-year to $227.3 million in Q1 2021; TTM through Mar 2021 was $384.5 million, a 1038.27% increase from a year earlier, with the FY2025 full-year figure at -$39.2 million, up 10.4% from the prior year.
  • Operating Income was $227.3 million for Q1 2021 at HUTCHMED (China), up from $54.2 million in the prior quarter.
  • Over five years, Operating Income peaked at $227.3 million in Q1 2021 and troughed at -$161.1 million in Q4 2018.
  • A 4-year average of $16.7 million and a median of $14.8 million in 2018 frame the typical range for Operating Income.
  • Across the five-year window, Operating Income slumped 343.04% in 2019 and surged 292.37% in 2020, its largest moves.
  • Over 4 years, Operating Income stood at -$161.1 million in 2018, then surged by 76.14% to -$38.4 million in 2019, then jumped by 241.06% to $54.2 million in 2020, then jumped by 319.28% to $227.3 million in 2021.
  • The last three Operating Income figures came in at $227.3 million (Q1 2021), $54.2 million (Q2 2020), and $141.5 million (Q1 2020), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Op. Inc (Qtr)
1 Amgen 212.20 Bn 198.21 Bn 7.24 Bn 3.51 Bn
2 Gilead Sciences 181.83 Bn 178.65 Bn 6.22 Bn -10.39 Bn
3 Vertex Pharmaceuticals 132.47 Bn 124.61 Bn 2.84 Bn 1.25 Bn
4 Regeneron Pharmaceuticals 82.56 Bn 74.56 Bn 3.93 Bn 1.29 Bn
5 Argenx Se 61.59 Bn 56.40 Bn 1.37 Bn 493.00 Mn
6 Moderna 54.65 Bn 49.51 Bn 52.00 Mn -815.00 Mn
7 Alnylam Pharmaceuticals 34.13 Bn 30.82 Bn 992.69 Mn 231.44 Mn
8 Biogen 31.42 Bn 30.13 Bn 1.96 Bn -644.50 Mn
9 Roivant Sciences 30.21 Bn 30.21 Bn 1.16 Mn -365.99 Mn
10 HUTCHMED (China) 376.85 Mn 391.04 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2021 227.32 Mn
Jun 30, 2020 54.22 Mn
Mar 31, 2020 141.45 Mn
Dec 31, 2019 -38.43 Mn
Sep 30, 2019 -35.94 Mn
Jun 30, 2019 -108.06 Mn
Mar 31, 2019 36.05 Mn
Dec 31, 2018 -161.11 Mn
Sep 30, 2018 14.79 Mn
Jun 30, 2018 78.70 Mn
Mar 31, 2018 -25.02 Mn